Next Article in Journal
Gene Interaction Network Analysis Reveals IFI44L as a Drug Target in Rheumatoid Arthritis and Periodontitis
Next Article in Special Issue
Formulation of Isopropyl Isothiocyanate Loaded Nano Vesicles Delivery Systems: In Vitro Characterization and In Vivo Assessment
Previous Article in Journal
Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells
Previous Article in Special Issue
Synthesis, Characterization, and Assessment of Anti-Cancer Potential of ZnO Nanoparticles in an In Vitro Model of Breast Cancer
 
 

Order Article Reprints

Journal: Molecules, 2022
Volume: 27
Number: 2748

Article: Development, In-Vitro Characterization and Preclinical Evaluation of Esomeprazole-Encapsulated Proniosomal Formulation for the Enhancement of Anti-Ulcer Activity
Authors: by Dibyalochan Mohanty, Ameeduzzafar Zafar, Mohammed Jafar, Atul Kumar Upadhyay, Mohammad Akiful Haque, Jeetendra Kumar Gupta, Vasudha Bakshi, Mohammed M. Ghoneim, Sultan Alshehri, Mohammed Asadullah Jahangir and Mohammed Javed Ansari
Link: https://www.mdpi.com/1420-3049/27/9/2748

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (articlereprints@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop